Reynders McVeigh Capital Management’s bluebird bio BLUE Stock Holding History

Reynders McVeigh Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-276	Closed	-$314K	–	195
2019 Q4	$314K	Sell	276 -37	-12%	-$40.2K	0.03%	191
2019 Q3	$372K	Sell	313 -73	-19%	-$111K	0.04%	160
2019 Q2	$637K	Buy	386 +3	+0.8%	+$5.19K	0.07%	129
2019 Q1	$780K	Sell	383 -9	-2%	-$15.8K	0.09%	113
2018 Q4	$504K	Sell	392 -133	-25%	-$204K	0.07%	126
2018 Q3	$993K	Hold	525	–	–	0.12%	98
2018 Q2	$1.07M	Buy	525 +19	+4%	+$43.3K	0.14%	96
2018 Q1	$1.12M	Buy	506 +1	+0.2%	+$2.54K	0.14%	91
2017 Q4	$1.16M	Hold	505	–	–	0.15%	87
2017 Q3	$898K	Sell	505 -77	-13%	-$108K	0.12%	102
2017 Q2	$792K	Hold	582	–	–	0.11%	109
2017 Q1	$685K	Buy	582 +167	+40%	+$170K	0.09%	121
2016 Q4	$331K	Buy	+415	New	+$330K	0.05%	172

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Reynders McVeigh Capital Management's BLUE Position: Q1 2020 in Review

Reynders McVeigh Capital Management sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 276 shares — an estimated $314K sold.

Reynders McVeigh Capital Management first reported a position in BLUE in Q4 2016 and held it in 13 quarters. The position peaked at $1.16M in Q4 2017. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

Reynders McVeigh Capital Management reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
Reynders McVeigh Capital Management sold 276 bluebird bio shares in Q1 2020, an estimated $314K.
Reynders McVeigh Capital Management first reported a position in bluebird bio in Q4 2016 and held it in 13 quarters.
Reynders McVeigh Capital Management's bluebird bio position peaked at $1.16M in Q4 2017.
247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2020, filed 13 May 2020.